Clinical Research Directory
Browse clinical research sites, groups, and studies.
Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)
Sponsor: Institut Curie
Summary
The IMMUNO-TET trial aims to assess the feasibility of characterising the immune environment of TETs and the constitutional and somatic molecular profiles of patients with localised thymic epithelial tumour (TET).
Official title: Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-08-03
Completion Date
2026-10-05
Last Updated
2025-09-08
Healthy Volunteers
No
Conditions
Interventions
single arm for all patients
* tumor samples will be taken for RNA sequencing of epithelial tumour cells during surgery. * blood samples will be taken for Exome Sequencing (WES) at baseline, during surgery and one month post surgery.
Locations (3)
Institut Curie Paris
Paris, France
Institut Mutualiste Montsouris
Paris, France
Hôpital FOCH
Suresnes, France